Your browser doesn't support javascript.
loading
Targeting Nrf2 may reverse the drug resistance in ovarian cancer.
Li, Danjie; Hong, Xiaoling; Zhao, Feijie; Ci, Xinxin; Zhang, Songling.
Afiliação
  • Li D; Department of Obstetrics and Gynecology, The First Hospital of Jilin University, Changchun, China.
  • Hong X; Department of Obstetrics and Gynecology, The First Hospital of Jilin University, Changchun, China.
  • Zhao F; Department of Obstetrics and Gynecology, The First Hospital of Jilin University, Changchun, China.
  • Ci X; Institute of Translational Medicine, The First Hospital of Jilin University, Changchun, China. cixinxin@jlu.edu.cn.
  • Zhang S; Department of Obstetrics and Gynecology, The First Hospital of Jilin University, Changchun, China. slzhang@jlu.edu.cn.
Cancer Cell Int ; 21(1): 116, 2021 Feb 17.
Article em En | MEDLINE | ID: mdl-33596893
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article